Fine Organics has announced a board meeting scheduled for February 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3). The trading window for dealing in the company’s equity shares remains closed from January 1, 2026, until February 14, 2026.
Board Meeting Announcement
A meeting of the Board of Directors of Fine Organics is scheduled to be held on Thursday, February 12, 2026. The primary agenda is to review and approve the company’s financial performance.
Financial Results on the Agenda
During the meeting, the board will consider and approve the unaudited Standalone and Consolidated financial results for the quarter and nine months which ended on December 31, 2025 (Q3).
Trading Window Closure
The trading window for dealing in equity shares of the company remains closed. This restriction, which began on January 1, 2026, will remain in effect until February 14, 2026. This closure adheres to the company’s internal code of conduct regarding insider trading regulations.
Source: BSE
